Interplay of angiotensin II and angiotensin(1–7) in the regulation of matrix metalloproteinases of human cardiocytes

@article{Pan2008InterplayOA,
  title={Interplay of angiotensin II and angiotensin(1–7) in the regulation of matrix metalloproteinases of human cardiocytes},
  author={Chun-Hsu Pan and Cheng-Hao Wen and Chih-Sheng Lin},
  journal={Experimental Physiology},
  year={2008},
  volume={93}
}
Angiotensin II (Ang II) is a critical effector in the renin–angiotensin system (RAS), which modulates cardiovascular homeostasis, and the matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) related metabolism of extracellular matrix (ECM). Angiotensin(1–7) [Ang(1–7)] is another bioactive peptide in the RAS and is considered to have opposite effects to Ang II. However, the modulation of MMPs and TIMPs by Ang(1–7) is largely unclear in cardiocytes, and the… 
Angiotensin II downregulates ACE2-mediated enhancement of MMP-2 activity in human cardiofibroblasts.
TLDR
Investigation of the regulatory relationships between Ang II, ACE2, and MMP-2 found that ACE2 expression was upregulated and downregulated in human cardiofibroblasts by lentiviral infection, and these data help to clarify how ACE2 and Ang II interact to regulate M MP-2 and control tissue remodeling in heart disease.
Different Effects of Angiotensin II and Angiotensin-(1-7) on Vascular Smooth Muscle Cell Proliferation and Migration
TLDR
Results suggest that Ang-(1-7) inhibits Ang II-induced SMC proliferation and migration, at least in part, through negative modulation of Ang II induced ERK1/2 activity.
New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis
TLDR
The axis formed by ACE2/Ang-(1–7)/Mas represents an endogenous counter regulatory pathway within the RAS whose actions are opposite to the vasoconstrictor/proliferative arm of the R AS constituted by ACE/Ang II/AT1 receptor.
Effects of Angiotensin-(1-7) in the Pathogenesis of Atherosclerosis
TLDR
The recent findings concerning the bioactivities of Ang-1-7 in atherosclerosis and the related mechanism of Ang-(1- 7) during atheros sclerosis development are summarized and the potential therapeutic strategies targeting the ACE2/Ang-( 1-7)/Mas axis were discussed.
Angiotensin-(1-7): new perspectives in atherosclerosis treatment
TLDR
Although clinical application of Ang-(1-7) is restricted due to its pharmacokinetic properties, identification of stabilized compounds, including more stable analogues and specific delivery compounds, has enabled clinical application and recent findings concerning the biological role and related mechanism during atherosclerosis development are discussed.
Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation
TLDR
Angiotensin-II induces a pro-fibrotic response in HMCs mainly via a dysregulation of the MMP-2/TIMP-2 pattern, suggesting another potential therapeutic application for this 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor.
The role of Angiotensin-(1-7) and Angiotensin-(1-9) in vascular remodelling
TLDR
This thesis investigated the interaction of Ang II and the counter-regulatory peptides Ang-(1-7) and Ang-( 1-9) in the vasculature using primary human VSMC and EC, and to provide a direct comparison of Ang-1-9 and Ang-2-9 in order to further understand their signal transduction pathways.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 68 REFERENCES
Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activities
TLDR
Ang II and AT1-R and AT2-R differentially affect the collagenase and gelatinase MMPs activities released by cardiac fibroblasts, which are associated with reperfusion injury occurring during open-heart surgery.
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
TLDR
Findings identify Mas as a functional receptor for Ang-(1–7) and provide a clear molecular basis for the physiological actions of this biologically active peptide.
Losartan Inhibits the Angiotensin II–Induced Modifications on Fibrinolysis and Matrix Deposition by Primary Human Vascular Smooth Muscle Cells
TLDR
Results indicate that AT 1 receptors are implicated in Ang II-mediated disorders of fibrinolysis and excessive ECM deposition by VSMC.
Angiotensin-(1-7) Downregulates the Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells
TLDR
It is demonstrated that pharmacological concentrations of Ang-(1-7) in the micromolar range cause a modest downregulation of the AT1 receptor on vascular cells and a reduction in Ang II–stimulated phospholipase C activity.
Angiotensin-(1–7): an update
Cardiovascular actions of angiotensin-(1-7).
  • A. J. Ferreira, R. A. Santos
  • Biology
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
  • 2005
TLDR
The biological relevance and potential of Ang-(1-7) and its receptor as a target for the development of new cardiovascular drugs are discussed, taking into account aspects related to its formation and effects on these tissues.
Angiotensin II Regulation of Collagen Type I Expression in Cardiac Fibroblasts: Modulation by PPAR-&ggr; Ligand Pioglitazone
Angiotensin II (Ang II)–mediated stimulation of fibroblast growth and collagen type I synthesis is believed to be an important component of the cardiac remodeling process in hypertension and chronic
Counterregulatory actions of angiotensin-(1-7).
TLDR
The accumulating evidence suggests that Ang-(1-7) may oppose the actions of Ang II either directly or by stimulation of prostaglandins and nitric oxide, which may explain the effective antihypertensive action of converting enzyme inhibitors in a variety of non-renin-dependent models of experimental and genetic hypertension as well as most forms of human hypertension.
Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
TLDR
Generation of Ang-(1-7) by proximal tubular ACE2 could thereby serve a protective role by counteracting the effects of locally generated Ang II, and inhibits Ang II-stimulated MAPK phosphorylation in proximaltubular cells.
Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects.
TLDR
Results suggest that ANG-(1-7) may play an important role in the heart in regulating cardiac remodeling and interacted with specific receptors on ARCFs to exert potential antifibrotic and antitrophic effects that could reverse ANG II effects.
...
1
2
3
4
5
...